Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Biosciences Inc (NASDAQ:CBIO)

5.03
Delayed Data
As of 9:30am ET
 0.00 / 0.00%
Today’s Change
3.11
Today|||52-Week Range
21.30
-48.42%
Year-to-Date
No recent news for Catalyst Biosciences Inc.

Today’s Trading

Previous close5.03
Today’s open5.03
Day’s range5.03 - 5.03
Volume311
Average volume (3 months)259,491
Market cap$21.7M
Dividend yield--
Data as of 9:30am ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+56.46%
Earnings growth (this year)+63.66%
Earnings growth (next 5 years)+35.40%
Revenue growth (last year)-77.20%
P/E ratioNM
Price/Sales19.04
Price/Book0.25

Competitors

 Today’s
change
Today’s
% change
NVGNNovogen Ltd0.000.00%
ABIOARCA Biopharma Inc+0.05+4.00%
OGENOragenics Inc+0.02+5.00%
ONTXOnconova Therapeutic...+0.01+0.41%
Data as of 9:30am ET, 10/23/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$1.32
Annual revenue (last year)$399.0K
Annual profit (last year)-$16.9M
Net profit margin-4,246.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nassim Usman
CFO &
Principal Accounting Officer
C. Fletcher Payne
Corporate headquarters
South San Francisco, California

Forecasts